Baseline Patterns of Substance Use Disorder Severity and Depression and Anxiety Symptoms Moderate the Efficacy of Mindfulness
Tracking # 20-984164
$99999.00
There are no ratings for this course
Learn moreCourse overview
This is a research intensive course that examines Mindfulness-based relapse prevention in patients with substance use disorder (AUD) and alcohol use disorder (AUD) with treatment moderates of depressive and anxiety symptoms. It includes: a literature review of Mindfulness-Based Relapse Prevention (MBRP), Relapse Prevention (RP), Cognitive Based therapy (CBT) , Dialectical Behavior Therapy (DBT); as sub classes of substance use, substance use severity, and depression and anxiety severity. This course is based on the reading-based online article, Baseline Patterns of Substance Use Disorder Severity and Depression and Anxiety Symptoms Moderate the Efficacy of Mindfulness-Based Relapse Prevention created by Corey Roos, Sara Bowen, PhD., and Katie Witkiewitz, PhD in 2018.
Subject areas
This course counts toward the state boards and subject areas below.
Ohio Counselor, Social Worker and Marriage and Family Therapist Board
Licensed Independent Marriage and Family Therapist
Licensed Independent Social Worker
Licensed Social Worker
Marriage and Family Therapist
Registered Social Worker Assistant
Disclosure statements
##### Disclosure of Relevant Financial Relationships
CE Learning Systems, LLC is an independent provider of continuing medical education. CE Learning Systems, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, CE Learning Systems, LLC is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest).
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and
- - any investigational, off-label, or non-FDA approved content or discussion
- CE Learning Systems, LLC has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
- Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- - All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- - All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- - Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
- ##### Planners
- The planners have reported the following: There are no relevant disclosures.
- ##### Course Material Authors
- The authors have disclosed any disclosures within the material.
- ##### Course Creator: L.A. Rankin
- There are no relevant disclosures.
- ##### Commercial support
- There is no commercial support for this distance-learning course.